docetaxel anhydrous has been researched along with folic acid in 56 studies
Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (folic acid) | Trials (folic acid) | Recent Studies (post-2010) (folic acid) |
---|---|---|---|---|---|
12,110 | 3,216 | 6,920 | 30,001 | 1,945 | 10,195 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (3.57) | 29.6817 |
2010's | 43 (76.79) | 24.3611 |
2020's | 11 (19.64) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Chang, EH; Pirollo, KF; Rait, AS; Ulick, D; Xiang, L | 1 |
Amini, M; Atyabi, F; Dinarvand, R; Esmaeili, F; Ghahremani, MH; Malekshahi, MR; Ostad, SN; Seyedabadi, M | 1 |
Feng, SS; Li, K; Liu, B; Liu, Y; Pan, J | 1 |
Chen, D; Yuan, Z; Zhang, S; Zheng, Z | 1 |
Feng, SS; Liu, Y; Mi, Y | 1 |
Feng, SS; Liu, Y; Mi, Y; Zhao, J | 1 |
Chen, RC; Copp, JA; Cox, AD; Cummings, ND; Karve, S; Li, C; Napier, ME; Sukumar, R; Wang, AZ; Werner, ME | 1 |
Diwan, PV; Komuravelli, R; Kuncha, M; Sistla, R; Venishetty, VK | 1 |
Li, M; Wang, L; Zhang, N | 1 |
Chen, C; Hou, L; Li, L; Li, Z; Shi, J; Wang, H; Wang, L; Wang, Z; Zhang, C; Zhang, H; Zhang, Z | 1 |
Gao, W; Liu, F; Meng, TT; Qi, XR; Xiang, B | 1 |
Astruc, D; Barratt, G; de Oliveira, R; de Santa Maria, LC; Li, N; Ruiz, J; Vergnaud, J; Zhao, P | 1 |
Gupta, S; Yadav, S | 1 |
Bloomfield, A; Dorton, R; Guan, J; Leamon, CP; Nelson, M; Reddy, JA; Vetzel, M | 1 |
Gong, X; Jiang, S; Zhao, X; Zu, Y | 1 |
Amini, M; Ghazi-Khansari, M; Gilani, K; Hami, Z; Rezayat, SM | 2 |
Amini, M; Atyabi, F; Dinarvand, R; Kamalinia, G; Khoshayand, MR; Ostad, SN; Rouhani, H; Tavassolian, F; Tehrani, MR | 1 |
Amiji, MM; Cacaccio, J; Coleman, TP; Ferris, CF; Ganta, S; Kulkarni, P; Patel, NR; Rawal, Y; Singh, A | 1 |
Hou, L; Huang, H; Huang, S; Shi, J; Xie, Y; Zhang, H; Zhang, Y; Zhang, Z; Zhu, X | 1 |
Huang, L; Liu, D; Liu, G; Liu, Y; Mei, L; Tao, W; Yu, Q; Zeng, X; Zhang, J; Zhu, X | 1 |
Hassanzadeh, F; Javanmard, SH; Rostami, M; Taymouri, S; Varshosaz, J | 1 |
Hassanzadeh, F; Javanmard, SH; Mahzouni, P; Taymouri, S; Varshosaz, J | 1 |
Amini, M; Atyabi, F; Dinarvand, R; Goodarzi, N; Khorramizadeh, MR; Nateghian, N | 1 |
Dana, N; Haghjooy Javanmard, S; Hassanzadeh, F; Taymouri, S; Varshosaz, J | 1 |
Gu, D; Hu, L; Hu, Q; Kong, D; Pang, S; Su, J; Xiong, X | 1 |
Hu, Y; Qin, F; Shou, D; Xu, B; Xu, J; Xu, Y | 1 |
Burman, R; Gill, MS; Pawar, H; Singh, C; Surapaneni, SK; Suresh, S; Tikoo, K | 1 |
Jiang, G; Liu, F; Liu, T; Wang, W; Wang, Y; Wu, T; Wu, X; Xie, M; Zhang, T | 1 |
Cun, X; Gao, H; He, Q; Hu, C; Hu, G; Kuang, Q; Ruan, S; Shi, K; Wang, Y; Xiao, W | 1 |
Afzal, SM; Dinesh, T; Kishan, V; Shareef, MZ | 1 |
Choi, HG; Choi, Y; Jeong, JH; Kim, JO; Thapa, RK; Yong, CS; Youn, YS | 1 |
Abnous, K; Alabdollah, F; Alibolandi, M; Hadizadeh, F; Mohammadi, M; Nassirli, H; Ramezani, M; Taghdisi, SM | 1 |
Bahadur, D; Sasidharan, S; Shanavas, A; Srivastava, R | 1 |
Bacich, DJ; Cummings, JL; O'Keefe, DS; Sobek, KM | 1 |
Chen, F; Gao, J; Hu, Y; Tao, J; Xu, B; Xu, J | 1 |
Cai, X; Sun, D; Wang, F; Yang, X; Zhai, G; Zhang, C | 1 |
Lillard, JW; Singh, R; Singh, SK | 1 |
Bora, C; Candiloro, KM; Coleman, TP; Connolly, DC; Davis, B; Galati, CA; Ganta, S; Litwin, S; Maglaty, MA; Morse, AB; Nack, AH; O'Brien, SW; Patel, NR; Piroyan, A; Solon, AL | 1 |
Bloomfield, A; Dircksen, C; Dorton, R; Kleindl, P; Leamon, CP; Nelson, M; Reddy, JA; Santhapuram, H; Vetzel, M; Vlahov, IR | 1 |
Chen, X; Kong, Y; Li, N; Liu, Q; Lu, X; Lu, Y; Xing, H; Xu, J; Yang, Y; Zhao, D; Zhu, X | 1 |
Chen, E; Chen, W; Chen, X; Ding, Y; Feijen, J; Huang, D; Qian, H; Qiao, H; Yang, D; Zhang, J | 1 |
Ravi Shankaran, D; Shruthi, S; Thambiraj, S; Vijayalakshmi, R | 1 |
Chen, L; Dong, C; Han, Y; Hu, X; Liang, S; Lin, Y; Liu, J; Lu, Y; Shi, S; Wang, C; Yao, T; Zhou, L | 1 |
Jiang, Z; Liu, J; Shu, M; Su, M; Xie, J; Zeng, Q | 1 |
Emami, J; Hasanzadeh, F; Kazemi, M; Lavasanifar, A; Minaiyan, M; Mirian, M; Mokhtari, M | 1 |
Agarwal, DS; Chitkara, D; Dalela, M; Mittal, A; Mohanty, S; Pukale, SS; Sahel, DK; Sakhuja, R; Sharma, S | 1 |
Abriata, JP; Chorilli, M; Emery, FDS; Luiz, MT; Marchetti, JM; Tofani, LB; Vaidergorn, MM; Viegas, JSR | 1 |
Alibolandi, M; Andisheh, F; Hadizadeh, F; Khodaverdi, E; Nassirli, H; Oroojalian, F; Ramezani, M; Shakour, N; Shamsara, J | 1 |
Chu, D; Guo, J; Han, S; O'Driscoll, CM; Song, L; Sun, B; Sun, D; Wang, L; Xiao, F; Yu, Z; Zou, Y | 1 |
Chitkara, D; Mittal, A; Pukale, S; Sahel, DK; Sharma, S; Singh, P | 1 |
Al-Nemrawi, NK; Altawabeyeh, RM; Darweesh, RS | 1 |
Avitabile, C; Conte, C; Dal Poggetto, G; Esposito, D; Laurienzo, P; Moret, F; Quaglia, F; Reddi, E; Romanelli, A; Tiso, N; Ungaro, F | 1 |
Kim, YJ; Lee, YJ; Park, Y | 1 |
Cai, X; Fang, Z; Li, L; Sui, F; Wan, X; Zhang, Y | 1 |
1 review(s) available for docetaxel anhydrous and folic acid
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
55 other study(ies) available for docetaxel anhydrous and folic acid
Article | Year |
---|---|
Tumor-targeting, systemically delivered antisense HER-2 chemosensitizes human breast cancer xenografts irrespective of HER-2 levels.
Topics: Animals; Antineoplastic Agents, Phytogenic; Docetaxel; Female; Folic Acid; Genes, erbB-2; Genetic Therapy; Genetic Vectors; Humans; Liposomes; Mammary Neoplasms, Experimental; Mice; Oligonucleotides, Antisense; Paclitaxel; Taxoids | 2002 |
Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA-PEG-folate conjugate.
Topics: Antineoplastic Agents; Carrier Proteins; Cell Line, Tumor; Cell Survival; Chromatography, High Pressure Liquid; Docetaxel; Drug Carriers; Endocytosis; Excipients; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Lactic Acid; Nanoparticles; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Receptors, Cell Surface; Taxoids | 2008 |
Folic acid conjugated nanoparticles of mixed lipid monolayer shell and biodegradable polymer core for targeted delivery of Docetaxel.
Topics: Biocompatible Materials; Cell Death; Cell Line, Tumor; Cell Survival; Docetaxel; Drug Delivery Systems; Folic Acid; Humans; Lipids; Microscopy, Confocal; Nanoparticles; Particle Size; Photoelectron Spectroscopy; Polymers; Surface Properties; Taxoids | 2010 |
Preparation, characterization and evaluation of docetaxel-loaded, folate-conjugated PEG-liposomes.
Topics: Animals; Antineoplastic Agents; Cells, Cultured; Docetaxel; Drug Delivery Systems; Female; Folic Acid; HeLa Cells; Humans; Liposomes; Male; Mice; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Taxoids; Tissue Distribution | 2010 |
Formulation of Docetaxel by folic acid-conjugated d-α-tocopheryl polyethylene glycol succinate 2000 (Vitamin E TPGS(2k)) micelles for targeted and synergistic chemotherapy.
Topics: Animals; Cell Line, Tumor; Cell Survival; Docetaxel; Folic Acid; Humans; Mice; Micelles; Microscopy, Confocal; Nanotechnology; NIH 3T3 Cells; Polyethylene Glycols; Polymers; Taxoids; Vitamin E | 2011 |
Multifunctional silica nanoparticles for targeted delivery of hydrophobic imaging and therapeutic agents.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Chromogenic Compounds; Diagnostic Imaging; Docetaxel; Drug Carriers; Folic Acid; Humans; Hydrophobic and Hydrophilic Interactions; Nanoparticles; Phosphatidylethanolamines; Polyethylene Glycols; Quantum Dots; Silicon Dioxide; Taxoids | 2011 |
Folate-targeted polymeric nanoparticle formulation of docetaxel is an effective molecularly targeted radiosensitizer with efficacy dependent on the timing of radiotherapy.
Topics: Animals; Biological Transport; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Docetaxel; Folic Acid; Folic Acid Transporters; Head and Neck Neoplasms; Humans; KB Cells; Mice; Molecular Targeted Therapy; Nanoparticles; Polymers; Radiation-Sensitizing Agents; Taxoids; Time Factors; Xenograft Model Antitumor Assays | 2011 |
Increased brain uptake of docetaxel and ketoconazole loaded folate-grafted solid lipid nanoparticles.
Topics: Animals; Brain; Cell Line; Docetaxel; Folic Acid; Ketoconazole; Lipids; Nanoparticles; Particle Size; Rats; Rats, Wistar; Taxoids | 2013 |
Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapy.
Topics: Animals; Antineoplastic Agents; Cell Survival; Docetaxel; Drug Carriers; Female; Folic Acid; Hep G2 Cells; Humans; Mice; Nanoparticles; Particle Size; Phosphatidylethanolamines; Polyethylene Glycols; Suspensions; Taxoids; Tissue Distribution; Xenograft Model Antitumor Assays | 2012 |
PEI-derivatized fullerene drug delivery using folate as a homing device targeting to tumor.
Topics: Administration, Intravenous; Animals; Apoptosis; Body Weight; Cell Line, Tumor; Cell Proliferation; Docetaxel; Drug Delivery Systems; Endocytosis; Female; Folic Acid; Fullerenes; Humans; Male; Mice; Mice, Inbred BALB C; Neoplasms; Particle Size; Polyethyleneimine; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Taxoids; Tissue Distribution; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |
Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Cell Survival; Cell-Penetrating Peptides; Docetaxel; Drug Carriers; Drug Delivery Systems; Female; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Ligands; Matrix Metalloproteinases; Mice; Mice, Nude; Molecular Sequence Data; Nanostructures; Neoplasms; Phosphatidylethanolamines; Polyethylene Glycols; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Spheroids, Cellular; Taxoids; Tumor Microenvironment | 2013 |
Synthesis and in vitro studies of gold nanoparticles loaded with docetaxel.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Docetaxel; Drug Carriers; Folic Acid; Gold; Humans; Metal Nanoparticles; Microscopy, Electron, Transmission; Mitochondria; Polyethylene Glycols; Taxoids | 2013 |
Development and in vitro characterization of docetaxel-loaded ligand appended solid fat nanoemulsions for potential use in breast cancer therapy.
Topics: Antineoplastic Agents; Biological Transport; Breast Neoplasms; Cholesterol; Docetaxel; Drug Carriers; Drug Discovery; Emulsions; Folic Acid; HeLa Cells; Humans; Ligands; Nanoparticles; Phosphatidylcholines; Polyethylene Glycols; Sonication; Taxoids; Triglycerides | 2015 |
Rational combination therapy of vintafolide (EC145) with commonly used chemotherapeutic drugs.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cell Line, Tumor; Cell Proliferation; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Folic Acid; HeLa Cells; Humans; Irinotecan; Mice, Inbred BALB C; Mice, Inbred DBA; Mice, Nude; Neoplasms; Neoplasms, Experimental; Paclitaxel; Taxoids; Topotecan; Treatment Outcome; Vinca Alkaloids; Xenograft Model Antitumor Assays | 2014 |
Preparation, characterization, and antitumor activities of folate-decorated docetaxel-loaded human serum albumin nanoparticles.
Topics: Animals; Animals, Outbred Strains; Antineoplastic Agents; Biological Transport; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Docetaxel; Drug Carriers; Drug Compounding; Drug Delivery Systems; Folic Acid; Humans; Liver Neoplasms, Experimental; Mice; Nanoparticles; Particle Size; Random Allocation; Sarcoma; Serum Albumin; Serum Albumin, Human; Solubility; Surface Properties; Taxoids | 2015 |
Synthesis and in vitro evaluation of a pH-sensitive PLA-PEG-folate based polymeric micelle for controlled delivery of docetaxel.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Docetaxel; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Drug Screening Assays, Antitumor; Folic Acid; Humans; Hydrogen-Ion Concentration; Lactic Acid; Micelles; Molecular Structure; Polyesters; Polyethylene Glycols; Polymers; Structure-Activity Relationship; Taxoids | 2014 |
Targeted poly (L-γ-glutamyl glutamine) nanoparticles of docetaxel against folate over-expressed breast cancer cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Survival; Chemistry, Pharmaceutical; Docetaxel; Drug Carriers; Female; Folate Receptors, GPI-Anchored; Folic Acid; Humans; MCF-7 Cells; Mice, Inbred BALB C; Microscopy, Confocal; Microscopy, Electron, Scanning; Nanoparticles; Nanotechnology; Peptides; Polyglutamic Acid; Proton Magnetic Resonance Spectroscopy; Solubility; Taxoids; Technology, Pharmaceutical; Time Factors; Tissue Distribution; Tumor Burden | 2014 |
Formulation development of a novel targeted theranostic nanoemulsion of docetaxel to overcome multidrug resistance in ovarian cancer.
Topics: Animals; Antineoplastic Agents; Bridged-Ring Compounds; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Docetaxel; Drug Carriers; Drug Delivery Systems; Drug Resistance, Multiple; Emulsions; Female; Folic Acid; Gadolinium; Humans; Mice; Mice, Nude; Nanoparticles; Ovarian Neoplasms; Particle Size; Taxoids; Theranostic Nanomedicine | 2016 |
In vitro and in vivo anti-cancer effects of targeting and photothermal sensitive solid lipid nanoparticles.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biological Transport; Cell Cycle; Cell Line, Tumor; Chemoradiotherapy; Docetaxel; Drug Carriers; Folic Acid; Humans; Mice; Nanoparticles; Nanotubes, Carbon; Particle Size; Taxoids | 2014 |
Blended nanoparticle system based on miscible structurally similar polymers: a safe, simple, targeted, and surprisingly high efficiency vehicle for cancer therapy.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biocompatible Materials; Cell Line, Tumor; Cell Survival; Docetaxel; Drug Delivery Systems; Drug Resistance, Neoplasm; Endocytosis; Female; Folic Acid; HeLa Cells; Humans; MCF-7 Cells; Mice; Mice, SCID; Nanoparticles; Neoplasms; Particle Size; Polyethylene Glycols; Polyglactin 910; Polyglycolic Acid; Polymers; Taxoids; Vitamin E | 2015 |
Folated synperonic-cholesteryl hemisuccinate polymeric micelles for the targeted delivery of docetaxel in melanoma.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Line, Tumor; Cholesterol Esters; Docetaxel; Drug Carriers; Drug Delivery Systems; Folic Acid; Hep G2 Cells; Humans; Melanoma, Experimental; Mice; Micelles; Particle Size; Polymers; Taxoids | 2015 |
Pharmacokinetics, Organ Toxicity and Antitumor Activity of Docetaxel Loaded in Folate Targeted Cholesterol Based Micelles.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cholesterol; Docetaxel; Drug Carriers; Folic Acid; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Micelles; Rats, Wistar; Taxoids | 2016 |
Biotin/Folate-decorated Human Serum Albumin Nanoparticles of Docetaxel: Comparison of Chemically Conjugated Nanostructures and Physically Loaded Nanoparticles for Targeting of Breast Cancer.
Topics: Antineoplastic Agents, Phytogenic; Biotin; Breast Neoplasms; Docetaxel; Female; Folic Acid; Humans; Nanoparticles; Serum Albumin; Taxoids | 2016 |
Optimisation of processing variables effective on self-assembly of folate targeted Synpronic-based micelles for docetaxel delivery in melanoma cells.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Cholesterol; Docetaxel; Drug Carriers; Folic Acid; Melanoma; Mice; Micelles; Polymers; Taxoids | 2015 |
Enhanced antitumor efficacy of folate targeted nanoparticles co-loaded with docetaxel and curcumin.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Proliferation; Cell Survival; Chemistry, Pharmaceutical; Curcumin; Docetaxel; Drug Carriers; Folic Acid; HeLa Cells; Humans; Lung Neoplasms; Mice, Inbred C57BL; Nanomedicine; Nanoparticles; Polyesters; Polyethylene Glycols; Sarcoma 180; Solubility; Taxoids; Time Factors; Tumor Burden | 2015 |
Characterization and evaluation of a folic acid receptor-targeted cyclodextrin complex as an anticancer drug delivery system.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Cyclodextrins; Docetaxel; Drug Carriers; Female; Folic Acid; Folic Acid Transporters; Humans; Mice, Inbred BALB C; Molecular Targeted Therapy; Neoplasms; Solubility; Taxoids; Tissue Distribution | 2016 |
Folic acid functionalized long-circulating co-encapsulated docetaxel and curcumin solid lipid nanoparticles: In vitro evaluation, pharmacokinetic and biodistribution in rats.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Chemistry, Pharmaceutical; Curcumin; Docetaxel; Drug Carriers; Drug Liberation; Female; Folic Acid; Humans; Lipids; MCF-7 Cells; Nanoparticles; Rats; Rats, Wistar; Taxoids; Tissue Distribution | 2016 |
Folate-targeted star-shaped cationic copolymer co-delivering docetaxel and MMP-9 siRNA for nasopharyngeal carcinoma therapy.
Topics: Animals; Apoptosis; beta-Cyclodextrins; Carcinoma; Cell Line, Tumor; Docetaxel; Drug Delivery Systems; Female; Folic Acid; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genetic Therapy; Humans; Hydrophobic and Hydrophilic Interactions; Magnetic Resonance Spectroscopy; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Mice, Nude; Micelles; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Polylysine; Proliferating Cell Nuclear Antigen; RNA, Small Interfering; Taxoids; Tissue Distribution; Transfection | 2016 |
Utilizing G2/M retention effect to enhance tumor accumulation of active targeting nanoparticles.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Disease Models, Animal; Docetaxel; Folic Acid; G2 Phase Cell Cycle Checkpoints; Humans; Ligands; Male; Mice; Molecular Imaging; Molecular Targeted Therapy; Nanoparticles; Neoplasms; Polyethylene Glycols; Polymers; Taxoids; Xenograft Model Antitumor Assays | 2016 |
Folate-PEG-decorated docetaxel lipid nanoemulsion for improved antitumor activity.
Topics: Animals; Antineoplastic Agents; Breast; Breast Neoplasms; Docetaxel; Drug Carriers; Drug Delivery Systems; Emulsions; Female; Folic Acid; HeLa Cells; Humans; Lipids; MCF-7 Cells; Mice, Inbred BALB C; Nanoparticles; Polyethylene Glycols; Taxoids | 2016 |
Folate-Mediated Targeted Delivery of Combination Chemotherapeutics Loaded Reduced Graphene Oxide for Synergistic Chemo-Photothermal Therapy of Cancers.
Topics: Antineoplastic Agents; Apoptosis; Camptothecin; Cell Survival; Docetaxel; Drug Carriers; Drug Liberation; Drug Synergism; Female; Folic Acid; Graphite; Hep G2 Cells; Humans; Irinotecan; MCF-7 Cells; Nanoparticles; Particle Size; Phototherapy; Surface Properties; Taxoids | 2016 |
Dextran-poly lactide-co-glycolide polymersomes decorated with folate-antennae for targeted delivery of docetaxel to breast adenocarcinima in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Cell Survival; Dextrans; Docetaxel; Drug Carriers; Drug Liberation; Folic Acid; Humans; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice, Inbred BALB C; Molecular Targeted Therapy; Polyesters; Taxoids; Tissue Distribution; Treatment Outcome | 2016 |
Magnetic core-shell hybrid nanoparticles for receptor targeted anti-cancer therapy and magnetic resonance imaging.
Topics: Antineoplastic Agents; Carbodiimides; Cell Line, Tumor; Chitosan; Contrast Media; Cross-Linking Reagents; Docetaxel; Drug Compounding; Drug Liberation; Epithelial Cells; Ferric Compounds; Folate Receptor 1; Folic Acid; Gene Expression; Humans; Hydrogen-Ion Concentration; Kinetics; Lactic Acid; Magnetic Resonance Imaging; Magnetite Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Taxoids | 2017 |
In-vitro cytotoxicity and combination effects of the docetaxel-conjugated and doxorubicin-conjugated poly(lactic acid)-poly(ethylene glycol)-folate-based polymeric micelles in human ovarian cancer cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Docetaxel; Doxorubicin; Drug Liberation; Drug Synergism; Folic Acid; Humans; Hydrogen-Ion Concentration; Micelles; Particle Size; Polyesters; Polyethylene Glycols; Taxoids | 2017 |
Contrasting roles of the ABCG2 Q141K variant in prostate cancer.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Docetaxel; Folic Acid; Gene Expression Regulation, Neoplastic; Humans; Male; MicroRNAs; Neoplasm Proteins; Neoplasm Recurrence, Local; Polymorphism, Single Nucleotide; Prostatic Neoplasms; Taxoids | 2017 |
Folate acid-Cyclodextrin/Docetaxel induces apoptosis in KB cells via the intrinsic mitochondrial pathway and displays antitumor activity in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Survival; Cyclodextrins; Docetaxel; Drug Delivery Systems; Folic Acid; Hematinics; Humans; KB Cells; Membrane Potential, Mitochondrial; Mice; Mitochondria; Neoplasms, Experimental; Reactive Oxygen Species; Taxoids | 2018 |
Multifunctional pH-Responsive Folate Receptor Mediated Polymer Nanoparticles for Drug Delivery.
Topics: Animals; Antineoplastic Agents; Cell Survival; Docetaxel; Drug Carriers; Endocytosis; Folic Acid; Folic Acid Transporters; Humans; Hydrogen-Ion Concentration; MCF-7 Cells; Nanoparticles; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Taxoids | 2016 |
Reversal of drug resistance by planetary ball milled (PBM) nanoparticle loaded with resveratrol and docetaxel in prostate cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line; Cell Line, Tumor; Cell Survival; Docetaxel; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Folic Acid; Humans; Male; Nanoparticles; Prostatic Neoplasms; Resveratrol | 2018 |
In Vitro and In Vivo evaluation of a novel folate-targeted theranostic nanoemulsion of docetaxel for imaging and improved anticancer activity against ovarian cancers.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Disease Models, Animal; Docetaxel; Drug Carriers; Emulsions; Endocytosis; Female; Folate Receptor 1; Folic Acid; Gadolinium; Humans; Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Mice, Transgenic; Molecular Imaging; Nanoparticles; Neoplasm Recurrence, Local; Ovarian Neoplasms; Theranostic Nanomedicine | 2018 |
Pre-clinical evaluation of EC1456, a folate-tubulysin anti-cancer therapeutic.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Cell Line, Tumor; Cisplatin; Docetaxel; Drug Evaluation, Preclinical; Folic Acid; Humans; Mice, Nude; Neoplasms; Oligopeptides; Paclitaxel; Pipecolic Acids; Topotecan; Tumor Burden; Xenograft Model Antitumor Assays | 2018 |
Inhalable dry powder prepared from folic acid-conjugated docetaxel liposomes alters pharmacodynamic and pharmacokinetic properties relevant to lung cancer chemotherapy.
Topics: Administration, Inhalation; Animals; Antineoplastic Agents; Docetaxel; Drug Delivery Systems; Dry Powder Inhalers; Folic Acid; Liposomes; Lung Neoplasms; Male; Particle Size; Powders; Rats; Rats, Sprague-Dawley; Tissue Distribution | 2019 |
Folated pH-degradable nanogels for the simultaneous delivery of docetaxel and an IDO1-inhibitor in enhancing cancer chemo-immunotherapy.
Topics: Animals; Biological Transport; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Docetaxel; Drug Carriers; Enzyme Inhibitors; Folic Acid; Hydrogen-Ion Concentration; Imidazoles; Immunotherapy; Indoleamine-Pyrrole 2,3,-Dioxygenase; Isoindoles; Mice; Nanoparticles; Polyvinyl Alcohol | 2019 |
Evaluation of cytotoxic activity of docetaxel loaded gold nanoparticles for lung cancer drug delivery.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Docetaxel; Drug Carriers; Folic Acid; Gold; Humans; Lung Neoplasms; Metal Nanoparticles | 2019 |
Tumor-Targeted Drug and CpG Delivery System for Phototherapy and Docetaxel-Enhanced Immunotherapy with Polarization toward M1-Type Macrophages on Triple Negative Breast Cancers.
Topics: Animals; Antibodies, Monoclonal, Humanized; Cell Line, Tumor; Cell Survival; Copper; Docetaxel; Drug Carriers; Folic Acid; Humans; Immunotherapy; Lasers; Mice; Nanocomposites; Oligonucleotides; Phototherapy; Polyethyleneimine; Protoporphyrins; Reactive Oxygen Species; T-Lymphocytes, Cytotoxic; Triple Negative Breast Neoplasms | 2019 |
Enzymatic synthesis of PEGylated lactide-diester-diol copolyesters for highly efficient targeted anticancer drug delivery.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colonic Neoplasms; Dioxanes; Docetaxel; Drug Carriers; Drug Compounding; Female; Folic Acid; Mice; Nanoparticles; Particle Size; Polyesters; Polyethylene Glycols; Xenograft Model Antitumor Assays | 2020 |
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Disease Models, Animal; Docetaxel; Endosomes; Female; Fibrinolytic Agents; Folate Receptor 1; Folic Acid; Heparin; Humans; In Vitro Techniques; Mice; Mice, Inbred BALB C; Micelles; Nanoparticles; Neoplasms; Patents as Topic | 2020 |
Folate-Targeted Cholesterol-Grafted Lipo-Polymeric Nanoparticles for Chemotherapeutic Agent Delivery.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cholesterol; Docetaxel; Drug Carriers; Female; Folic Acid; Humans; Mice; Nanoparticles; Polymers; Rats; Rats, Sprague-Dawley | 2020 |
Docetaxel-loaded folate-modified TPGS-transfersomes for glioblastoma multiforme treatment.
Topics: Antineoplastic Agents; Cell Line, Tumor; Docetaxel; Drug Carriers; Folic Acid; Glioblastoma; Humans; Nanoparticles; Vitamin E | 2021 |
Docetaxel encapsulation in nanoscale assembly micelles of folate-PEG-docetaxel conjugates for targeted fighting against metastatic breast cancer in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Docetaxel; Drug Carriers; Female; Folic Acid; Humans; Mice; Mice, Inbred BALB C; Micelles; Polyethylene Glycols | 2021 |
A folate-targeted PEGylated cyclodextrin-based nanoformulation achieves co-delivery of docetaxel and siRNA for colorectal cancer.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Colorectal Neoplasms; Cyclodextrins; Docetaxel; Folic Acid; Mice; Nanoparticles; Polyethylene Glycols; RNA, Small Interfering | 2021 |
Folate targeted hybrid lipo-polymeric nanoplexes containing docetaxel and miRNA-34a for breast cancer treatment.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Docetaxel; Drug Carriers; Female; Folic Acid; Humans; MicroRNAs; Nanoparticles; Polymers | 2021 |
Preparation and Characterization of Docetaxel-PLGA Nanoparticles Coated with Folic Acid-chitosan Conjugate for Cancer Treatment.
Topics: Chitosan; Docetaxel; Folic Acid; Humans; Lactic Acid; Nanoparticles; Neoplasms; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2022 |
Biodegradable nanoparticles combining cancer cell targeting and anti-angiogenic activity for synergistic chemotherapy in epithelial cancer.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Docetaxel; Drug Carriers; Endothelial Cells; Folic Acid; Nanoparticles; Neoplasms; Zebrafish | 2022 |
Folic Acid and Chitosan-Functionalized Gold Nanorods and Triangular Silver Nanoplates for the Delivery of Anticancer Agents.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Chitosan; Docetaxel; Folic Acid; G2 Phase Cell Cycle Checkpoints; Gold; HeLa Cells; Humans; Metal Nanoparticles; Nanotubes; Paclitaxel; Silver | 2022 |
pH-triggered "PEG" sheddable and folic acid-targeted nanoparticles for docetaxel delivery in breast cancer treatment.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Docetaxel; Drug Carriers; Female; Folic Acid; Humans; Hydrogen-Ion Concentration; Nanoparticles; Polyethylene Glycols | 2023 |